Brief: Hikal Gets EIR Report For Panoli Pharmaceutical Facility With Zero 483 Observations
12/12/2019 09:44
Dec 12 (Reuters) - Hikal Ltd HIKA.NS :
* GETS EIR REPORT FOR US FDA INSPECTION OF PHARMACEUTICAL
FACILITY
AT PANOLI, GUJARAT WITH ZERO 483 OBSERVATIONS
Source text: https://www.bseindia.com/xml-data/corpfiling/AttachLive/a082a884-4800-464a-af59-b9a9781ae51e.pdf
Further company coverage: HIKA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hikal
See all newsBrief: Hikal Begins Commercial Production At New Cgmp Panoli Facility For Personal Care
Brief: Hikal June-Quarter Consol Loss 74 Million Rupees
India's Hikal slips after quarterly profit slump
Brief: Hikal March-Quarter Consol Net Profit 144 Million Rupees
India's Hikal down after revenue reporting discrepancies flagged